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Aims There is growing evidence that magnetic resonance imaging (MRI) scanning in patients with non-conditional cardiac
implantable electronic devices (CIEDs) can be performed safely. Here, we aim to assess the safety of MRI in




English scientific literature was searched using PubMed/Embase/CINAHL with keywords of ‘magnetic resonance im-
aging’, ‘pacemaker’, ‘implantable defibrillator’, and ‘cardiac resynchronization therapy’. Studies assessing outcomes
of adverse events or significant changes in CIED parameters after MRI scanning in patients with non-conditional
CIEDs were included. References were excluded if the MRI conditionality of the CIEDs was undisclosed; number
of patients enrolled was <10; or studies were case reports/series. 35 cohort studies with a total of 5625 patients
and 7196 MRI scans (0.5–3 T) in non-conditional CIEDs were included. The overall incidence of lead failure, electri-
cal reset, arrhythmia, inappropriate pacing and symptoms related to pocket heating, or torque ranged between 0%
and 1.43%. Increase in pacing lead threshold >0.5 V and impedance >50X was seen in 1.1% [95% confidence inter-
val (CI) 0.7–1.8%] and 4.8% (95% CI 3.3–6.4%) respectively. The incidence of reduction in P- and R-wave sensing
by >50% was 1.5% (95% CI 0.6–2.9%) and 0.4% (95% CI 0.06–1.1%), respectively. Battery voltage reduction of
>0.04 V was reported in 2.2% (95% CI 0.2–6.1%).
...................................................................................................................................................................................................
Conclusion This meta-analysis affirms the safety of MR imaging in non-conditional CIEDs with no death or implantable
cardioverter-defibrillator shocks and extremely low incidence of lead or device-related complications.
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Introduction
The use of cardiac implantable electronic devices (CIEDs) is on the
rise due to prolonged life expectancy and the expanding indications
for CIEDs implantation. It has been estimated that the need for a
magnetic resonance imaging (MRI) scan within one year of device im-
plantation and over the lifetime of the patient with CIED is around
10% and 75%, respectively.1 With the recent development of
MRI-conditional CIEDs, MRI scanning in patients with MRI-
conditional CIEDs is increasingly being performed. However, a recent
population-based cohort study showed that around 90% of all CIEDs
in current use are non-conditional in the MRI environment.2
Traditionally, MRI has been considered contraindicated in the CIED
population, due to safety concerns relating to the exposure to static
and gradient magnetic fields as well as radiofrequency energy. As a
result, patients with older generation non-conditional CIEDs are
likely to be denied access to MRI scans in many centres.
There is growing evidence that MRI scanning in patients with non-
conditional CIEDs can be performed safely without patient harm or
clinically significant changes in CIEDs parameters with appropriate
device programming, patient screening and monitoring.3 To this end,
the 2017 Heart Rhythm Society expert consensus statement pro-
vided a Class IIa recommendation (level of evidence B) for MRI scan-
ning of non-conditional CIEDs.4 More recently, the evidence base for
the safety of MRI scanning in non-conditional CIEDs has grown signifi-
cantly with additional data from almost 2000 patients.5–7 Here, we
performed an updated systematic review and meta-analysis to evalu-
ate the safety of MRI scanning in patients with non-conditional CIEDs.
Methods
Literature search and data sources
This meta-analysis was registered on PROSPERO (CRD42019118485)
and conducted in accordance with the MOOSE guidelines
(Supplementary material online, Table S1). Searches were conducted us-
ing the medical scientific electronic databases: PubMed, EMBASE, and
CINAHL from inception to 5 December 2018 to identify all relevant
studies. The search used keywords of ‘magnetic resonance imaging’ AND
‘pacemaker’ OR ‘implantable cardioverter defibrillator’ OR ‘cardiac
resynchronization therapy’. The search was limited to the articles in the
English language and human studies. All references obtained through the
Graphical Abstract
What’s new?
• Magnetic resonance imaging (MRI) in patients with non-condi-
tional cardiac implantable electronic devices (CIEDs) is safe
when strict programming protocol and patient monitoring are
adhered to.
• This meta-analysis showed that in 5625 patients with non-con-
ditional CIEDs, MRI-related adverse events were low and
changes in CIED parameters were non-clinically significant.
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databases were reviewed manually. Bibliographies of retrieved articles
and reviews were searched manually for additional publications.
Study selection and quality assessment
Citations were included if the following criteria were met: (i) enrol-
ment of patients with non-conditional CIEDs undergoing MRI scan-
ning; and (ii) adverse events during or immediately after MRI scanning
were assessed. Studies were excluded if the MRI conditionality of the
CIEDs was undisclosed or if they included <10 patients or if they
were review/case reports/series. Eligibility assessment was performed
independently by two investigators (D.A.M. and J.E.Z.C.).
Disagreements were resolved by consensus. Selected publications
were analysed for the following outcomes: (A) adverse events relating
to MRI scans, comprising of (i) death; (ii) peri-procedural symptoms—
including heating or torque at generator site, chest pain, or palpitation;
(iii) electrical reset—defined as reversion to manufacturer’s specified
parameters (indicated as Safety Mode, Reset Parameters, or Back-Up
mode); (iv) lead failure—defined as failure of lead function requiring
replacement or revision; (v) generator failure—defined as inability to
communicate with CIEDs via device programmer or sudden drop in
battery voltage requiring replacement; and (vi) inappropriate pacing;
(B) changes in CIEDs parameters, comprising of: (i) pacing lead
threshold increase (>_0.5 V, >_1.0 V, or >_50%); (ii) amplitude decrease
(>_50% for P wave and >_25% and >_50% for R wave); (iii) pacing lead
impedance increase (>_50% or >_50X); and (iv) battery voltage de-
crease (>0.04 V).
Data extraction sheet was developed based on Cochrane Consumers
and Communication Review Group’s data extraction template and re-
fined accordingly. Assessment of the methodological quality of clinical tri-
als included was performed according to the Cochrane Collaboration’s
tool for assessing risk of bias. The relevant checklists are included in the
Supplementary material online.
4609 references
Article screened on basis of title and abstract
3114 references included
Full text manuscript review
278 references included
35 references included
Studies with non-MRI devices only (n= 26 studies)
Studies with MRI and non-MRI devices (n= 9 studies)
1495 duplication removed
Search engine: Pubmed and Embase, and manual bibliography searching







2836 irrelevant references excluded:
-    MRI in non-transvenous CIEDs
-    MRI in other cardiac conditions
-    MRI-guided ventricular tachycardia ablation
39 references excluded:
-    MRI conditional devices (n= 31 studies)
-    Repetitive publication (n= 4 studies)
-    Device conditionality not specified (n= 4 studies)
204 references excluded:
-    Case reports and case series
-    Cohorts
-    Review articles
-    Conference abstracts
Figure 1 A CONSORT diagram showing search methodology. CIED, cardiac implantable electronic device; MRI, magnetic resonance imaging.
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Statistical analysis
This meta-analysis was carried out utilizing the StatsDirect Statistical soft-
ware (Version 3.1.21, StatsDirect Ltd, Cambridge, UK). For nominal val-
ues, the pooled weighted proportion was used with its 95% confidence
interval (CI). The Mantel–Haenszel fixed effect and the Der Simonian–
Laird random effect models were followed when heterogeneity was
found among studies by means of I2 and the statistical Cochran’s Q tests.
I2 values of <25%, 25–50, and >50% normally correspond to small, me-
dium, and large heterogeneity, respectively. Statistical significance was de-
fined as P < 0.05.
Results
A total of 4609 English citations were identified using the search strat-
egy. After removing duplication, 3114 studies were screened based
on the title and abstract. A total of 2836 studies were excluded on ac-
count of relevance (Figure 1). After secondary review of the full-text
articles in the remaining 278 selected studies, 204 studies were ex-
cluded because they were review articles, case reports or case series,
cohort studies, or conference abstracts. A total of 39 studies were
excluded due to repetitive publication (n = 4), not including non-
conditional devices (n = 31), and undisclosed conditionality of the
CIEDs (n = 4). As a result, 35 cohort studies (Supplementary material
online Table S2) with a total of 5625 patients and 7196 MRI scans
(0.5–3 T) in non-conditional CIEDs were included in the analysis
(Table 1).
Of the 35 included studies, 31 studies (n = 5518) utilized 1.5 T MRI,
three studies (n = 78) utilized >1.5 T MRI, and one study utilized both
1.5 and 3 T MRI (n = 29).8 Ten studies recruited pacemaker-
dependent patients (n = 561), in which two of these patients had 3 T
MRI. There was a total of 2622 atrial pacing leads, 3124 right ventricu-
lar pacing leads, 289 left ventricular pacing leads, and 1851 defibrilla-
tor leads. None of the patients with abandoned (n = 26) or epicardial
leads (n = 8) had 3 T MRI. Majority of the MRI scans were for head
and neck (39%), spinal (17%), and abdomen/pelvis regions (12%). The
details of the study design are provided in Table 2.
Adverse events relating to magnetic
resonance imaging scans
Figure 2 demonstrates the pooled proportion of peri-procedural
events.
Death
Magnetic resonance imaging scan-related mortality was reported in
nine studies (n = 2122 patients). These studies showed no death oc-
curred during or immediately after the procedure.
Symptom of heating or torque
Symptom associated with either torque or heating of the generator
or lead, chest pain, or palpitation, induced by MRI was described in
25 studies (n = 4531 patients) with an overall incidence of 0.71%
(95% CI 0.35–1.18%).
Electrical reset
Of 25 studies (n = 4896 patients), electrical resets occurred in 76
patients with 83 MRI scans, yielding the absolute incidence of 1.43%
(95% CI 0.64–2.54). Notably, in the studies disclosing the details of
these devices, all resets occurred in older generation CIEDs that
were first released in the market before 2005 (Supplementary mate-
rial online, Table S4).
Lead and generator failure
Fifteen studies (3995 patients) examined the outcome of lead or gen-
erator failure. Of these, there were no cases of non-conditional lead
failure reported. Additionally, two cases of generator failure were
reported in two studies, with pooled absolute incidence of 0.14%
(95% CI 0.05–0.28%). In one study, the implantable cardioverter-
defibrillator (ICD) generator could not be interrogated during post-
MRI evaluation. However, it was reported that anti-tachycardia ther-
apy was left in the active mode during MRI, therefore, multiple anti-
tachycardia pacing therapy attempts due to false ventricular fibrilla-
tion detection were notable in this particular case.9 The other study
showed battery longevity <1 month following an electrical reset,
which resulted in the inability to change mode due to battery status.5
Both devices were immediately replaced.
Inappropriate pacing
A total of 2772 patients were included in 16 studies reporting the
outcome of inappropriate pacing. This analysis showed an incidence
of 0.37% (95% CI 0.09–0.53). Most cases demonstrated a decrease in
heart rate temporarily during MRI procedure due to pacing inhibition,
except in one case, the pacing rate was increased to magnet rate
(Guidant Insignia).
Implantable cardioverter-defibrillator shocks
No ICD shocks occurred during MRI scans of non-conditional ICDs
(10 studies, n = 911 patients). In these studies, tachyarrhythmia thera-
pies including anti-tachycardia pacing and shocks, were deactivated
before the MRI scans.
.................................................................................................
Table 1 Composite study characteristics by MRI type
1.5 T >1.5 T
Number of studies 32 4
Number of patients 5541 84
Number of pacemaker-dependent patients 559 2
Number of devices
Permanent pacemaker 3506 75
Implantable cardioverter-defibrillator 1845 6
Implantable loop recorder 9 1
Leads
Atrial leads 2554 68
Right ventricular leads 3046 78
Left ventricular leads 281 1
Defibrillator leads 1845 6
Abandoned leads 26 0
Epicardial leads 8 0
MRI, magnetic resonance imaging.
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Changes in cardiac implantable
electronic device parameters
The pooled proportion of patients who had changes in the CIED
parameters before and after MRI scans were analysed (Figure 3).
Lead threshold
Twelve studies with a total of 7987 leads in 3604 patients reported
the incidence of increased pacing threshold. Pooled analysis was per-
formed in the group of studies stratified by an absolute increase of
>_0.5 V (six studies), >_1.0 V (four studies), or >_ 50% (two studies). A
significant increase in pacing threshold was observed in 1.1% (95% CI
0.7–1.8%; I2 34.5%), 1.0% (95% CI 0.1–2.9%; I2 69.3%), and 1.1% (95%
CI 0.2–2.8%; I2 81.6%), respectively.
Lead impedance
Eight studies (n = 3284 patients, 7713 leads) analysed the change in
lead impedance. The incidence of impedance changes >50X (five
studies) and >50% (three studies) in low voltage devices was 4.8%
(95% CI 3.3–6.4%; I2 62.9%) and 0%, respectively. There were 132 of
727 scans (n = 658 patients) with high voltage lead impedance change
of >3X (22.4%, 95% CI 13.7–32.5%; I2 70.5%).
P- and R-wave sensing
The incidence of decreased P- and R-wave amplitudes of >_50% were
reported in six (n = 3274 patients, 2883 leads) and five studies
(n = 3165 patients, 3515 leads), respectively. The pooled incidence of
the decrease in P- and R-wave sensing were 1.5% (95% CI 0.6–2.9%;
I2 77.5%) and 0.4% (95% CI 0.06–1.1%; I2 74.4%), respectively.
Battery voltage
Five studies (n = 1453 patients) evaluated the incidence of battery
voltage drop of >0.04 V, with an incidence of 2.2% (95% CI 0.2–6.1%;
I2 90.3%).
Risk of bias within studies
The risk of bias assessment in the included studies is shown in
Supplementary material online, Table S5. All the studies included
cohorts with appropriate study methodology and minimum risk of
bias. No study was excluded based on study quality.
Discussion
This systematic review and meta-analysis of 5625 patients with non-
conditional CIEDs who underwent 7196 MRI scans demonstrate no
cases of death, ICD shocks or lead failure. The rate of adverse events
was as follows: electrical reset (1.43%), symptom of heating or torque
(0.71%), inappropriate pacing (0.37%), and generator failure (0.14%).
Significant increase in lead pacing threshold was seen in up to 1.1%,
while P- and R-wave sensing reduction of >50% was seen in 1.5% and
0.4%, respectively. Changes in pacing lead impedance of >50X and
high voltage lead impedance of >3X were 4.8% and 22.4%, respec-
tively, while decrease in battery voltage of >0.02 V was seen in 2.2%.
Taken together, this meta-analysis affirms the safety of MR imaging
in non-conditional CIEDs with very low incidence of adverse events
and non-significant changes in lead parameters. Of note, the evidence
for MRI safety in patients with non-conditional CIEDs was derived
primarily from scanners of <_1.5 T. Of all 35 studies, only four studies
performed MRI with 2T and 3 T machines. It remains unknown
whether higher Tesla MRI scans will translate into higher theoretical
2.5




















































Electrical reset Lead failure Generator failure ICD shocksInappropriate pacing
Figure 2 Incidence of MRI-related adverse events. ICD, implantable cardioverter-defibrillator; MRI, magnetic resonance imaging.
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risks of adverse events. Interestingly, evidence from ex vivo experi-
ments showed less temperature increase with 3 T as compared to
1.5 T MRI scans.10
Potential hazards of magnetic resonance
imaging environment to cardiac
implantable electronic devices
Magnetic resonance imaging scans are traditionally contraindicated in
patients with CIEDs due to initial reports of deaths when appropriate
screening, reprogramming, and monitoring were not in place.11
Potential interactions of CIEDs with the magnetic resonance environ-
ment can be due to one of the three electromagnetic fields present,
namely the static magnetic field, gradient magnetic field, and radiofre-
quency field.12 First, the radiofrequency and gradient magnetic fields
in the MRI environment can produce high currents to result in the
heating of the CIEDs’ lead tip and injury of the surrounding myocar-
dial tissue, leading to increases in pacing threshold and impedance.13
In this meta-analysis, we found low incidence of changes in pacing
lead parameters of sensing amplitude, pacing threshold, and imped-
ance. Although the incidence of high voltage lead impedance changes
of >3X appears high, this is likely of no clinical significance given that
lead fractures were highly suspected only with abrupt impedance in-
crease of >75% or >100X.14. Second, there is a potential of myocar-
dial stimulation due to the radiofrequency and magnetic fields, leading
to triggering of dangerous arrhythmias, inappropriate tachycardia or
inappropriate pacing inhibition. While tachyarrhythmia therapy deliv-
ery during MRI is not likely to occur because of saturation in the mag-
netic field, permanent device failure might still happen after a given
number of unsuccessful attempts to charge capacitor.15 Our analysis
did not find any significant issues with arrhythmias induction, inappro-
priate pacing or tachyarrhythmia therapy when appropriate CIEDs
programming was undertaken for the MRI scans. Third, CIEDs can be
susceptible to magnetic force and torque exerted by the static mag-
netic field of the MRI scanner, resulting in pulling or torque sensation
without clinical consequences.16 Reassuringly, <1% of the patients in
our meta-analysis reported this symptom. Fourth, older generation
CIEDs have magnet-activated reed switch that is aimed at preventing
any interference during electrocautery surgery. However, when reed
switch is activated by the static magnetic field, asynchronous pacing
occurs at magnet rate and tachycardia therapy is disabled with poten-
tial risk for untreated tachyarrhythmias as well as accelerated battery
depletion. Last, there is a risk of electrical reset of CIEDs in the MRI
environment by any of the three electromagnetic fields that reverts
all programming to factory default settings. In this meta-analysis, elec-
trical reset appears to be occurring only in older generation devices
that were first marketed before 2005.
Notably, all the included studies disclosed strict programming and
monitoring protocol during the MRI scanning procedure. In general,
CIEDs were programmed into asynchronous pacing, particularly in
studies enrolling pacemaker dependent patients, or monitor only for
non-pacemaker dependent patients. Tachyarrhythmia therapies, in-
cluding anti-tachycardia pacing and shocks, were turned off during
MRI scans. MRI procedures were supervised by either cardiologists
or cardiac nurses who were trained in advanced cardiac life support
and cardiac technicians with experience in device programming.
Patient monitoring included a minimum of electrocardiogram and
pulse oximetry.
Current practice of magnetic resonance
imaging scans in patients with cardiac
implantable electronic devices
Despite the availability of MRI-conditional devices and increasing evi-
dence in the safety of MRI in non-conditional CIEDs, access for MRI






























































































Incidence of CIED parameter changes
Figure 3 Incidence of CIED parameter changes. CIED, cardiac implantable electronic device.
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study reported that in almost 17 000 patients with CIEDs, only 0.3%
of patients had MRI.2 In addition, it is also shown that MRI utilization
is lower in ICD patients compared to non-ICD patients despite simi-
lar comorbidities.17 In contrast, in well-prepared MRI centres, emer-
gency MRI scans could also be performed safely in CIEDs patients.18
Indeed, there are multiple barriers contributing to low rates of MRI
uptake in the CIED population. The lack of MRI centres that provide
services to CIEDs population might be one of the major reasons.19 In
more equipped MRI centres, real-world practice based on the cur-
rent radiological guidelines is often limited to offering MRI scans to
patients with CIEDs that are labelled as MRI-conditional.20
However, the 2017 HRS expert consensus Class IIa recommenda-
tion and the reaffirmed overall safety of MRI scans in patients with
non-conditional CIEDs in this updated meta-analysis may encourage
more MRI centres to offer scans to patients with non-conditional
CIEDs with appropriate programming and monitoring protocol in
place. Undoubtedly, the additional measures required to ensure MRI
safety such as the expertise to determine clinical risk-benefit and suit-
ability of CIEDs for MRI, to perform pre- and post-scan device pro-
gramming, to manage any device-related adverse events and to
arrange future follow-up; may continue to pose significant issues as
these are resource-intensive and require close coordination between
radiology and cardiology services.19
Study limitations
Our study was limited by observational cohort design in all included
studies and their inherent potential biases. Several of the studies did
not disclose the number of MRI scans based on device conditionality,
so that data analysis based on the number of MRI scans could not be
performed. In addition, more than half of the studies have small num-
ber of participants, which may underestimate the actual incidence of
adverse events. Furthermore, significant study heterogeneity was evi-
dent in some of the analysis, partly because of the high number of
possible combinations between device generator and lead models,
MRI scanners with various field strengths, or different body areas
scanned. The nature of the available data precluded differentiation
between partial and full electrical reset of CIEDs. Information on the
age of the CIEDs leads and the time between leads implants to MRI
scanning were unavailable.
Conclusion
This systematic review and meta-analysis affirm the safety of MRI
scanning in patients with non-conditional CIEDs when a strict selec-
tion and monitoring protocol is utilised.
Supplementary material
Supplementary material is available at Europace online.
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Combined computed tomographic perfusion and mechanics with predicted
activation pattern can successfully guide implantation of a wireless
endocardial pacing system
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The WiSE-CRT system (EBR Systems, CA, USA)
delivers wireless endocardial left ventricular (LV) pac-
ing and has a number of advantages, including early
access to fast endocardial conduction and a pacing
location unconstrained by coronary anatomy.
Currently, the optimal location for the electrode is
unknown. Pacing in an area of latest mechanical acti-
vation and avoiding myocardial scar is advisable. We
hypothesized that cardiac computed tomography
with dynamic perfusion would have the ability to iden-
tify areas of heterogenous perfusion and when com-
bined with areas of latest mechanical and electrical
activation, would be able to identify the optimal loca-
tion for the endocardial electrode. A 70-year-old
patient with ischaemic cardiomyopathy was listed for
a WiSE-CRT system after their epicardial left ventric-
ular lead resulted in phrenic nerve stimulation in all
configurations. Cardiac computed tomography with
dynamic perfusion identified areas of perfusion heter-
ogeneity, latest mechanical and electrical activation,
which were combined to predict the optimal pacing
location between the basal inferior (coloured orange
in Figure 1) and inferolateral (coloured red in Figure 1)
segments. During the procedure, these segments
were overlaid onto live fluoroscopy as shown in
Figure 1 and the greatest improvement in haemody-
namic measurements corresponded to this target seg-
ment which was where the electrode was deployed.
The full-length version of this report can be viewed at: https://www.escardio.org/Education/E-Learning/Clinical-cases/Electrophysiology.
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